verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: northwind health company, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler northwind health company, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

verapamil hydrochloride 180 mg/1

Manufacturer
Northwind Health Company, LLC

Identifiers & Regulatory

Product NDC 51655-734
Product ID 51655-734_4963a8f3-e774-0c08-e063-6394a90a6a17
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206173
Listing Expiration 2027-12-31
Marketing Start 2021-06-17

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51655734
Hyphenated Format 51655-734

Supplemental Identifiers

RxCUI
897640
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA206173 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE, PLASTIC (51655-734-52)
source: ndc

Packages (1)

Ingredients (1)

verapamil hydrochloride (180 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4963a8f3-e774-0c08-e063-6394a90a6a17", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897640"], "spl_set_id": ["db990ce1-b193-4a81-e053-2a95a90a627b"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (51655-734-52)", "package_ndc": "51655-734-52", "marketing_start_date": "20210617"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "51655-734_4963a8f3-e774-0c08-e063-6394a90a6a17", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51655-734", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20210617", "listing_expiration_date": "20271231"}